Engrail Therapeutics Inc

This study tested whether a new medication called ENX-102 helps reduce anxiety symptoms in adults with generalized anxiety disorder. Researchers compared ENX-102 against a placebo in 252 participants over several weeks. The main goal was to see if people taking ENX-102 experience…

This study tested a new drug called ENX-104 in people with major depression who also experience anhedonia, which is a loss of interest or pleasure. The main goal was to see if the drug was safe and how the body processes it. The study involved 48 participants and was an early-sta…

This study tested a new medication called ENX-102 for people with Generalized Anxiety Disorder (GAD). The main goals were to check if the drug was safe and to find the best dose. Thirty-eight adults with GAD participated, and some received the drug while others received a placebo…

This early-stage study tested a single oral dose of a new drug called ENX-104 in 10 healthy volunteers. The main goals were to see if it was safe, how it moved through the body, and how much it attached to specific targets in the brain using PET scans. This type of study helps re…